City

Clinical trials near Milan, Italy

Active studies with a listed research site in Milan, Italy.

21active studies

15recruiting now

31countries represented

93largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Diabetes Mellitus, OverweightCondition

NNC0487-0111, Placebo (matched to NNC0487-0111)Treatment

Argentina, Brazil74 locations

Novo Nordisk A/SSponsor

Updated 2026-09-04 · NCT07533175See eligibility →

Recruiting nowNot applicable

EffectiVenEss of a Rehabilitation Treatment With Nordic Walking in obEse or oveRweight Patients

Cardiovascular Diseases, Diabete Type 2Condition

Nordic Walking (NW), Standard Rehabilitation (SR)Treatment

Italy1 locations

Fondazione Don Carlo Gnocchi ETSSponsor

Updated 2026-09-03 · NCT05987410See eligibility →

Recruiting nowPhase 3

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Obesity, OverweightCondition

NNC0487-0111, Placebo (matched to NNC0487-0111)Treatment

Australia, Bulgaria81 locations

Novo Nordisk A/SSponsor

Updated 2026-08-17 · NCT07509307See eligibility →

Recruiting nowPhase 4

Fibrosis Lessens After Metabolic Surgery

Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver DiseaseCondition

Metabolic surgery, Incretin-Based TherapyTreatment

Brazil, Canada22 locations

The Cleveland ClinicSponsor

Updated 2026-07-31 · NCT06374875See eligibility →

Recruiting nowPhase 3

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Obesity, Knee Osteoarthritis (OA)Condition

NNC0487-0111, Placebo (matched to NNC0487-0111 )Treatment

Australia, Bulgaria82 locations

Novo Nordisk A/SSponsor

Updated 2026-07-09 · NCT07481630See eligibility →

Recruiting nowNot applicable

Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer

Colorectal Cancer, Early Onset Colorectal CancerCondition

Semi Quantitative Food Frequency Questionnaire (SQFFQ)Treatment

Finland, Germany8 locations

San Raffaele UniversitySponsor

Updated 2026-04-24 · NCT05732623See eligibility →

Recruiting nowNot applicable

Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment

Obesity & OverweightCondition

Myosave®, PlaceboTreatment

Italy3 locations

Pharmanutra S.p.a.Sponsor

Updated 2026-03-23 · NCT07393360See eligibility →

Recruiting nowNot applicable

Abnormal Eating and Taste Perception in Subjects With Obesity

ObesityCondition

Intervention not listedTreatment

Italy1 locations

Istituto Auxologico ItalianoSponsor

Updated 2025-10-03 · NCT05772052See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Modulation of Perceived Satiety

Obesity, MorbidCondition

Sleeve gastrectomy, OverStitch™ Endoscopic Suturing SystemTreatment

Italy1 locations

Istituto Auxologico ItalianoSponsor

Updated 2025-10-03 · NCT05777928See eligibility →

Recruiting nowNot applicable

Early Detection of Renal Abnormalities in Metabolically Healthy and Unhealthy Weight Excess"

ObesityCondition

DietTreatment

Italy2 locations

Istituto Auxologico ItalianoSponsor

Updated 2025-08-03 · NCT06338631See eligibility →

Recruiting nowNot applicable

Dissecting the Molecular and Cellular Pathophysiology of Sarcopenic Obesity in the Elderly

Sarcopenic ObesityCondition

clinical evaluation of sarcopenic obesityTreatment

Italy1 locations

IRCCS San RaffaeleSponsor

Updated 2025-06-18 · NCT06320158See eligibility →

Recruiting nowNot applicable

Type 2 Diabetes, Obesity and Cortisol Excess

Diabetes Mellitus, Type 2, ObesityCondition

1mg DSTTreatment

Italy5 locations

Istituto Auxologico ItalianoSponsor

Updated 2025-03-24 · NCT05759637See eligibility →

Recruiting nowNot applicable

Impact of Bariatric Surgery and Liraglutide on Cognitive-Behavioral Markers of Long-Term Weight Loss in Obesity

Obesity and OverweightCondition

Intervention not listedTreatment

Italy1 locations

I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioSponsor

Updated 2024-12-11 · NCT06720246See eligibility →

Recruiting nowNot applicable

Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression

Prostate Cancer, Prostate AdenocarcinomaCondition

observational studyTreatment

Italy1 locations

Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoSponsor

Updated 2024-03-05 · NCT06292897See eligibility →

Recruiting nowNot applicable

The European NAFLD Registry

NAFLD, NASHCondition

Intervention not listedTreatment

Belgium, Finland37 locations

Newcastle UniversitySponsor

Updated 2023-01-06 · NCT04442334See eligibility →

Opening soonPhase 3

A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes

Diabetes Mellitus, Type 2Condition

Orforglipron, DulaglutideTreatment

Belgium, Brazil71 locations

Eli Lilly and CompanySponsor

Updated 2026-08-19 · NCT07668336See eligibility →

Opening soonNot applicable

The OB-WELL Project, a Randomized Controlled Trial of an Internet-Based Self-Help System for Psychological Support in Obesity

Obesity (BMI > 35)Condition

BST Internet-based intervention, CBT Internet-based interventionTreatment

Italy1 locations

Catholic University of the Sacred HeartSponsor

Updated 2026-03-17 · NCT07476599See eligibility →

Active, not recruitingPhase 3

Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide

Obesity, OverweightCondition

Cagrilintide, PlaceboTreatment

Argentina, Australia40 locations

Novo Nordisk A/SSponsor

Updated 2026-08-06 · NCT07220642See eligibility →

Active, not recruitingPhase 4

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

ObesityCondition

SemaglutideTreatment

Belgium, Canada93 locations

Novo Nordisk A/SSponsor

Updated 2026-06-02 · NCT06571383See eligibility →

Active, not recruitingPhase 4

A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes

Type 2 DiabetesCondition

Tirzepatide, Antihyperglycemic medicationTreatment

Argentina, Canada90 locations

Eli Lilly and CompanySponsor

Updated 2025-12-12 · NCT05433584See eligibility →

Active, not recruitingNot applicable

Long Term Effect of Very-low-calories Ketogenic Diet on Weight Control and Cardiovascular Brisk Factors (KETOHEART)

Obesity, Morbid ObesityCondition

VLCKD, r-MedDietTreatment

Italy1 locations

Istituto Auxologico ItalianoSponsor

Updated 2025-10-03 · NCT05781269See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Milan, Italy

Current studies

Related cities